On the basis of the high frequency of megakaryocyte involvement in CML patients and the concurrent thrombocytosis in our patient, we assumed that platelet dysfunction was a manifestation of CML and that the megakaryocytes also carried the BCR-ABL fusion gene. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.